Suzanne Morgan | Executive Director, Market Access
Stealth BioTherapeutics

Suzanne Morgan, Executive Director, Market Access, Stealth BioTherapeutics

Suzanne Morgan, PhD, MBA, is an Executive Director,  Head of Market Access with more than 30 years of leadership experience across the pharmaceutical and biotechnology industries.  She is recognized for her expertise in market access strategy, payer engagement, patient access solutions, and commercialization planning for emerging and established healthcare organizations.  Suzanne brings a unique perspective at the intersection of academic research and real-work corporate complexity, translating evidence-based principles into parctical strategies that drive organizational performance and patient access.  Throught her career, she has leed cross-functional teams, developed innovative access programs, and partnered with stakeolders across the healthcare ecosystem to improve healthcare delivery.  A respected industry leader and speaker, Suzanne is passionate about authentic leadership, developing hlgh-performing teams,  writing about AI Innovation and Rare Disease on LinkedIN, advancing patient-centered healthcare thorugh strategic innovation and collaboration.  

Appearances:



Day 2 - World Orphan Drug Congress USA 2026 @ 14:00

Presentation: The AI Revolution in Rare Disease

last published: 04/Jun/26 19:45 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 

 

To Sponsor Or Exhibit

 
 

Jack Rendell
jack.rendell@terrapinn.com
t/ +44 07577689029

 

 

 

To Speak

 
 

Abdu Kauroo
abdu.kauroo@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Jasper Cameron
jasper.cameron@terrapinn.com